Mesh.i
Checkpoint
Ncbi
Racine
Checkpoint
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur les pandémies grippales - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Drug Industry »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drug Evaluation, Preclinical < Drug Industry < Drug Interactions  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000085 (2003) David S. Fedson [France]Pandemic influenza and the global vaccine supply.
000158 (2004) Klaus Stöhr [Suisse] ; Marja EsveldPublic health. Will vaccines be available for the next influenza pandemic?
000187 (2005) David S. FedsonPreparing for Pandemic Vaccination: An International Policy Agenda for Vaccine Development
000224 (2005) Erica SeiguerProtecting the nation's health: ensuring a stable supply of influenza vaccine.
000503 (2007) Kenneth Hughes [Canada] ; Alicja Zachertowska ; Simmy Wan ; Lily Li ; Damian Klimaszewski ; Michelle Euloth ; Todd F. HatchetteYield increases in intact influenza vaccine virus from chicken allantoic fluid through isolation from insoluble allantoic debris.
000752 (2008) Rissah J. Watkins [États-Unis] ; Daniel J. Barnett ; Jonathan M. LinksCorporate preparedness for pandemic influenza: a survey of pharmaceutical and biotechnology companies in Montgomery County, Maryland.
000A32 (2009) Nigel J. Silman [Royaume-Uni] ; Liza M. Rivera ; Jenifer WheatPhacilitate vaccine forum Barcelona 2009.
000B65 (2010) Pritish K. Tosh ; Robert M. Jacobson ; Gregory A. PolandInfluenza Vaccines: From Surveillance Through Production to Protection
000D07 (2010) Jeffrey Partridge [Suisse] ; Marie Paule KienyGlobal production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets.
000F21 (2011) A S Hollister [États-Unis] ; W P SheridanThe emergency use authorization of peramivir IV: a view from the manufacturer.
001432 (2012) Thomas Strecker [Allemagne] ; Jennifer Uhlendorff ; Sandra Diederich ; Claudia Lenz-Bauer ; Heidi Trusheim ; Bernhard Roth ; Larissa Kolesnikova ; Christian Aepinus ; Reiner Dornow ; Jens Gerlach ; Mikhail Matrosovich ; Ulrich Valley ; Markus Eickmann ; Stephan BeckerExploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens.
001A43 (2015) Britta Lundgren‘Rhyme or reason?’ Saying no to mass vaccination: subjective re-interpretation in the context of the A(H1N1) influenza pandemic in Sweden 2009–2010
001B86 (2016) Laszlo Palkonyay [Suisse] ; Hiba Fatima [Suisse]A decade of adaptation: Regulatory contributions of the World Health Organization to the Global Action Plan for Influenza Vaccines (2006-2016).

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Drug Industry" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Drug Industry" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Drug Industry
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021